Kazuko Nagase

1.2k total citations
36 papers, 927 citations indexed

About

Kazuko Nagase is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Kazuko Nagase has authored 36 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Kazuko Nagase's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (6 papers) and Pharmacological Effects of Natural Compounds (4 papers). Kazuko Nagase is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (6 papers) and Pharmacological Effects of Natural Compounds (4 papers). Kazuko Nagase collaborates with scholars based in Japan, United States and Somalia. Kazuko Nagase's co-authors include Kazuhide Iwasaki, Ken Fukunaga, Toshifumi Shiraga, Kenji Iwasaki, Hiroto Miwa, Kosei NODA, Shirô Nakamura, Yoko Yokoyama, Koji Kamikozuru and Nobuyuki Hida and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Kazuko Nagase

35 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuko Nagase Japan 16 336 294 243 219 191 36 927
Camille Tron France 16 214 0.6× 58 0.2× 149 0.6× 130 0.6× 112 0.6× 46 568
C.R. Stiller Canada 11 124 0.4× 81 0.3× 110 0.5× 49 0.2× 108 0.6× 17 687
Jacky Woo United States 15 58 0.2× 95 0.3× 86 0.4× 193 0.9× 141 0.7× 40 922
Bernhard Ryffel France 14 138 0.4× 32 0.1× 109 0.4× 93 0.4× 145 0.8× 23 1.2k
Olga Millán Spain 18 482 1.4× 13 0.0× 93 0.4× 159 0.7× 307 1.6× 46 852
K H Stenzel United States 18 90 0.3× 47 0.2× 40 0.2× 125 0.6× 75 0.4× 39 943
Sheila Zuckerman United States 7 735 2.2× 21 0.1× 430 1.8× 62 0.3× 265 1.4× 11 963
Mari Thörn Sweden 9 28 0.1× 181 0.6× 64 0.3× 182 0.8× 82 0.4× 12 407
Marie‐Claude Gagnieu France 19 82 0.2× 18 0.1× 102 0.4× 273 1.2× 97 0.5× 63 889
Keith Nieforth United States 16 101 0.3× 18 0.1× 43 0.2× 249 1.1× 51 0.3× 31 792

Countries citing papers authored by Kazuko Nagase

Since Specialization
Citations

This map shows the geographic impact of Kazuko Nagase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Nagase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Nagase more than expected).

Fields of papers citing papers by Kazuko Nagase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Nagase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Nagase. The network helps show where Kazuko Nagase may publish in the future.

Co-authorship network of co-authors of Kazuko Nagase

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Nagase. A scholar is included among the top collaborators of Kazuko Nagase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Nagase. Kazuko Nagase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nagase, Kazuko, Kazutoshi Hori, Shenglan Wang, et al.. (2014). Xilei San Ameliorates Experimental Colitis in Rats by Selectively Degrading Proinflammatory Mediators and Promoting Mucosal Repair. Evidence-based Complementary and Alternative Medicine. 2014(1). 569587–569587. 16 indexed citations
3.
4.
Yokoyama, Yoko, Mikio Kawai, Ken Fukunaga, et al.. (2013). Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA. BMC Gastroenterology. 13(1). 27–27. 24 indexed citations
6.
Yokoyama, Yoko, Ken Fukunaga, Hiroki Ikeuchi, et al.. (2011). The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy. Cytokine. 56(2). 466–470. 21 indexed citations
7.
Yoshida, Kōji, Ken Fukunaga, Hiroki Ikeuchi, et al.. (2011). Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial. Inflammatory Bowel Diseases. 18(9). 1617–1623. 106 indexed citations
8.
Fukunaga, Ken, Koji Kamikozuru, Yoko Yokoyama, et al.. (2011). Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis. Journal of Clinical Apheresis. 26(6). 326–331. 3 indexed citations
9.
Fukunaga, Ken, Yoko Yokoyama, Koji Kamikozuru, et al.. (2010). Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease. Journal of Clinical Apheresis. 25(4). 226–228. 19 indexed citations
10.
Fukunaga, Ken, Kazuko Nagase, Takeshi Kusaka, et al.. (2009). Cytapheresis in Patients with Severe Ulcerative Colitis after Failure of Intravenous Corticosteroid: A Long-Term Retrospective Cohort Study. Gut and Liver. 3(1). 41–47. 3 indexed citations
11.
Tozawa, Katsuyuki, Ken Fukunaga, Koji Kamikozuru, et al.. (2008). Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: Relevance to extracorporeal immunomodulation. Transfusion and Apheresis Science. 39(2). 129–135. 3 indexed citations
13.
Sawada, Koji, Kunio Ohnishi, Ken Fukunaga, et al.. (2003). Granulocyte and Monocyte Adsorptive Apheresis for Patients with Chronic Hepatitis C Virus Infection: A Report on Six Cases with High Plasma Viremia. Therapeutic Apheresis and Dialysis. 7(6). 547–553. 5 indexed citations
14.
Takahashi, Yasuko, et al.. (1995). Effect of Sonolysis on Acid Degradation of Chitin to Form Oligosaccharides. Bulletin of the Chemical Society of Japan. 68(7). 1851–1857. 19 indexed citations
15.
Nagase, Kazuko, et al.. (1994). Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by Erythrocytes. Journal of Pharmacy and Pharmacology. 46(2). 113–117. 96 indexed citations
16.
Nagase, Kazuko, Kazuhide Iwasaki, Kosei NODA, et al.. (1994). Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochemical Pharmacology. 47(4). 727–735. 113 indexed citations
17.
Iwasaki, Kenji, Toshifumi Shiraga, Kazuko Nagase, et al.. (1993). Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.. Drug Metabolism and Disposition. 21(6). 971–977. 88 indexed citations
18.
Iwasaki, Kenji, et al.. (1993). Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes.. PubMed. 82(2). 209–16. 49 indexed citations
20.
Nakazawa, Shozo, et al.. (1968). Oral antibiotics of the cephalosporin C group:Fundamental studies on cephachlomezine. 21(6). 331–335. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026